Charles Brynelsen - 22 May 2025 Form 4 Insider Report for Envoy Medical, Inc. (COCH)

Role: Director
Signature: /s/ Andrew Nick as Attorney-in-Fact for Charles Brynelsen pursuant to Power of Attorney previously filed.
Issuer symbol: COCH
Transactions as of: 22 May 2025
Transactions value $: $82,403
Form type: 4
Date filed: 27 May 2025, 18:34
Previous filing: 17 Oct 2023
Next filing: 05 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
BRYNELSEN CHARLES	Director	C/O 4875 WHITE BEAR PARKWAY, WHITE BEAR LAKE	/s/ Andrew Nick as Attorney-in-Fact for Charles Brynelsen pursuant to Power of Attorney previously filed.	2025-05-27	0001712459

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COCH	Class A Common Stock	Purchase	$3.37K	+2K		$1.68	2K	22 May 2025	Direct	F1
transaction	COCH	Class A Common Stock	Purchase	$21.4K	+13K	+650%	$1.64	15K	23 May 2025	Direct	F2
transaction	COCH	Class A Common Stock	Purchase	$57.7K	+35K	+233.33%	$1.65	50K	27 May 2025	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	COCH	Stock Option (right to buy)						62.5K	22 May 2025	Class A Common Stock	62.5K	$2.40	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6875 to $1.6794 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6333 to $1.6497 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F3	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.6345 to $1.65 inclusive. The reporting person undertakes to provide Envoy Medical, Inc., any security holder of Envoy Medical, Inc., or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F4	Options to purchase 46,875 shares vest on 10/15/2023, and the remaining 15,625 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.